UGC Approved Journal no 63975(19)

ISSN: 2349-5162 | ESTD Year : 2014
Call for Paper
Volume 11 | Issue 5 | May 2024

JETIREXPLORE- Search Thousands of research papers



WhatsApp Contact
Click Here

Published in:

Volume 6 Issue 4
April-2019
eISSN: 2349-5162

UGC and ISSN approved 7.95 impact factor UGC Approved Journal no 63975

7.95 impact factor calculated by Google scholar

Unique Identifier

Published Paper ID:
JETIR1904F35


Registration ID:
206511

Page Number

194-200

Share This Article


Jetir RMS

Title

ANTISENSE THERAPY AND ITS UNIQUE APPLICATION TO TREAT GENETIC DISORDERS-A REVIEW

Abstract

A genetic disorder is a genetic problem caused by one or more abnormalities formed in the genome. Most genetic disorders are quite rare and affect one person in every several thousands or millions. Genetic disorders may be hereditary, meaning that they are passed down from the parents' genes. In other genetic disorders, defects may be caused by new mutations or changes to the DNA. The principle behind the technology is that an antisense nucleic acid sequence base pairs with its complementary sense RNA strand and prevents it from being translated into a protein or the inhibition of RNA processing yields the therapeutic result.The Oligonucleotide are used to block coded massage carried by mRNA this known as antisense therapy the primary sequence of mRNA called oligonucleotide contains nucleic acid bases complimentry to mRNA molecule. An oligonucleotide has a complimentry base sequence called antisense oligonucleotide, when mixed with mRNA antisense oligonucleotide Recognize mRNA and forms duplex and act as barrier to translation process and block protein synthesis. Antisense drugs have the potential therapeutic efficacy in the treatment of various diseases than the conventional drug. The rapid development of antisense technology offers almost unlimited scope for the development of new and highly specific therapeutics. Antisense therapeutics therefore is well positioned to play a significant role in the progression of antisense technology for drug development in human diseases.

Key Words

Antisense therapy, genetic disorder, oligonucleotide, protein, Nucleic acid.

Cite This Article

"ANTISENSE THERAPY AND ITS UNIQUE APPLICATION TO TREAT GENETIC DISORDERS-A REVIEW", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.6, Issue 4, page no.194-200, April-2019, Available :http://www.jetir.org/papers/JETIR1904F35.pdf

ISSN


2349-5162 | Impact Factor 7.95 Calculate by Google Scholar

An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 7.95 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator

Cite This Article

"ANTISENSE THERAPY AND ITS UNIQUE APPLICATION TO TREAT GENETIC DISORDERS-A REVIEW", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.6, Issue 4, page no. pp194-200, April-2019, Available at : http://www.jetir.org/papers/JETIR1904F35.pdf

Publication Details

Published Paper ID: JETIR1904F35
Registration ID: 206511
Published In: Volume 6 | Issue 4 | Year April-2019
DOI (Digital Object Identifier):
Page No: 194-200
Country: Ahamednagar, Maharashtra, India .
Area: Pharmacy
ISSN Number: 2349-5162
Publisher: IJ Publication


Preview This Article


Downlaod

Click here for Article Preview

Download PDF

Downloads

0002860

Print This Page

Current Call For Paper

Jetir RMS